BRWM
ATHE

B. Riley Wealth Management’s Alterity Therapeutics ATHE Stock Holding History

B. Riley Wealth Management’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-135
Closed -$13K – 1020
2014
Q4 		$13K Hold
135
– – 0.01% 675
2014
Q3 		$17K Hold
135
– – 0.01% 649
2014
Q2 		$18K Hold
135
– – 0.01% 680
2014
Q1 		$23K Buy
+135
New +$74.6K 0.02% 599

Other funds holding ATHE

GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CAM
Columbia Asset Management Ann Arbor, Michigan $575M AUM 29.81% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $1.87B AUM 29.51% 1-Year Est. Return
NCCM
Nine Chapters Capital Management Short Hills, New Jersey $45.4M AUM 14.43% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

B. Riley Wealth Management's ATHE Position: Q1 2015 in Review

B. Riley Wealth Management sold out of Alterity Therapeutics (ATHE) in Q1 2015, closing a stake of 135 shares — an estimated $13K sold.

B. Riley Wealth Management first reported a position in ATHE in Q1 2014 and held it in 4 quarters. The position peaked at $23K in Q1 2014. 21 funds tracked by Wall St. Rank hold ATHE as of Q1 2015.

  • B. Riley Wealth Management reported no remaining Alterity Therapeutics position as of Q1 2015 after selling out during the quarter.
  • B. Riley Wealth Management sold 135 Alterity Therapeutics shares in Q1 2015, an estimated $13K.
  • B. Riley Wealth Management first reported a position in Alterity Therapeutics in Q1 2014 and held it in 4 quarters.
  • B. Riley Wealth Management's Alterity Therapeutics position peaked at $23K in Q1 2014.
  • 21 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q1 2015.

Based on B. Riley Wealth Management's 13F filing for Q1 2015, filed 13 Apr 2015.